The procedure was performed at the University Hospital of Tübingen in Germany. Professor Martin U. Schuhmann, a pediatric neurosurgeon, performed the biopsy.
“Performing a successful biopsy is the first step to finding a biological cure which scientists believe is the only chance to beat this terrible disease,” said Ori Hadomi, CEO of the company. “Mazor Robotics’ mission is to make a difference.”
More articles on devices:
K2M sets follow-on offering at $18.75 per share — 5 things to know
Implanet’s JAZZ technology receives intellectual patent protection in Europe
FTC makes second request for additional information on Wright Medical-Tornier merger — 5 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
